Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone Taper After Total Knee Replacement
NCT05859269Phase 4Completed
- Sponsor
- Emory University
- Start
- Oct 2023
- Primary completion
- Jul 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of methylprednisolone injection in knee osteoarthritis (OA) (2 arms), sponsored by Emory University. Primary endpoints: Changes in Pain Score at day 7 and Changes in Nausea score at day 7. Started Oct 2023; status: completed.
02
Drugs
methylprednisolone injection
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05859269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05859269.